133 related articles for article (PubMed ID: 15293789)
1. V-erba homodimers mediate the potent dominant negative activity of v-erba on everted repeats.
Zubkova I; Subauste JS
Mol Biol Rep; 2004 Jun; 31(2):131-7. PubMed ID: 15293789
[TBL] [Abstract][Full Text] [Related]
2. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
Zubkova I; Subauste JS
Mol Cell Endocrinol; 2003 Jan; 199(1-2):61-72. PubMed ID: 12581880
[TBL] [Abstract][Full Text] [Related]
3. Dimerization of v-erbA on inverted repeats.
Zubkova I; Subauste JS
Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
[TBL] [Abstract][Full Text] [Related]
4. Dimerization interfaces of v-erbA homodimers and heterodimers with retinoid X receptor alpha.
Shen Q; Subauste JS
J Biol Chem; 2000 Dec; 275(52):41018-27. PubMed ID: 11018031
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the DNA-binding and dominant negative activity of v-erbA homodimers.
Subauste JS; Koenig RJ
Mol Endocrinol; 1998 Sep; 12(9):1380-92. PubMed ID: 9731706
[TBL] [Abstract][Full Text] [Related]
6. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
Harbers M; Wahlström GM; Vennström B
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor.
Yoh SM; Privalsky ML
J Biol Chem; 2001 May; 276(20):16857-67. PubMed ID: 11278601
[TBL] [Abstract][Full Text] [Related]
8. Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6.
Busch K; Martin B; Baniahmad A; Martial JA; Renkawitz R; Muller M
Mol Endocrinol; 2000 Feb; 14(2):201-11. PubMed ID: 10674394
[TBL] [Abstract][Full Text] [Related]
9. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
10. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
11. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
12. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
13. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
15. Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors.
Bonamy GM; Guiochon-Mantel A; Allison LA
Mol Endocrinol; 2005 May; 19(5):1213-30. PubMed ID: 15650025
[TBL] [Abstract][Full Text] [Related]
16. At least three subdomains of v-erbA are involved in its silencing function.
Busch K; Martin B; Baniahmad A; Renkawitz R; Muller M
Mol Endocrinol; 1997 Mar; 11(3):379-89. PubMed ID: 9058383
[TBL] [Abstract][Full Text] [Related]
17. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.
Chen HW; Privalsky ML
Mol Cell Biol; 1993 Oct; 13(10):5970-80. PubMed ID: 8105369
[TBL] [Abstract][Full Text] [Related]
18. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
19. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
Rascle A; Ghysdael J; Samarut J
Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
Burke LJ; Downes M; Laudet V; Muscat GE
Mol Endocrinol; 1998 Feb; 12(2):248-62. PubMed ID: 9482666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
